You are here:
Information Letter on Exelon® and Prometax® transdermal patches: incorrect administration and medication error
2010.04.29
Active substance: rivastigmine
In association with the rivastigmine transdermal patches, Exelon® and Prometax®, cases of overdosage due to medication errors and incorrect administration have been reported.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN